Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screenedPrevious open label trial ...
Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screened Previous open label trial data presented at SIRS 2026 showed no safety or drug-dr ...
Explore the 25 Most Mind-boggling Discoveries Ever Made that shattered assumptions and rewrote history. From ancient tech to ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to ...
The development of artificial intelligence-generated content (AIGC) technology brings new opportunities for the teaching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results